CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-08-14 | ACCBT Corp. 10% owner | Purchase | +20,500 | $1.08 | $22K | 7,075,000 |
| 2007-08-13 | ACCBT Corp. 10% owner | Purchase | +16,000 | $1.05 | $17K | 7,075,000 |
| 2007-08-13 | ACCBT Corp. 10% owner | Purchase | +29,500 | $1.05 | $31K | 7,075,000 |
| 2007-08-10 | ACCBT Corp. 10% owner | Purchase | +13,500 | $1.00 | $14K | 7,075,000 |
| 2007-08-10 | ACCBT Corp. 10% owner | Purchase | +20,500 | $0.97 | $20K | 7,075,000 |
| 2007-08-10 | ACCBT Corp. 10% owner | Exercise or conversion | +6,875,000 | $0.18 | $1.2M | 7,075,000 |
| 2007-08-10 | ACCBT Corp. 10% owner | Exercise or conversion · Warrant to Purchase Common Stock | +7,562,500 | 7,562,500 | ||
| 2007-08-10 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −6,875,000 | 20,625,000 | ||
| 2007-08-10 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Warrant to Purchase Common Stock | −7,562,500 | 22,687,500 | ||
| 2007-08-09 | ACCBT Corp. 10% owner | Purchase | +8,500 | $1.02 | $9K | 7,075,000 |
| 2007-08-09 | ACCBT Corp. 10% owner | Purchase | +66,500 | $1.01 | $67K | 7,075,000 |
| 2007-08-02 | ACCBT Corp. 10% owner | Purchase · Right to Acquire Warrant to Purchase Common Stock | +3,181,925 | 3,181,925 | ||
| 2007-07-16 | Lion Moshe Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2007-07-01 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2007-07-01 | SHORR ROBERT G L Director | Grant or award | +100,000 | 400,000 | ||
| 2007-07-01 | GREENFIELD MICHAEL D Director | Grant or award | +100,000 | 400,000 | ||
| 2007-03-21 | GREENFIELD MICHAEL D Director | Grant or award | +100,000 | 300,000 | ||
| 2007-03-21 | Drucker Yoram Chief Operating Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2007-03-21 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2007-03-21 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 20 of 22 · 426 trades